ABSTRACT
In their 2012 guidelines for cervical cancer screening, several organizations call for less-frequent but more-effective screening that incorporates testing for human papillomavirus (HPV). We review these recommendations and the possible future direction of screening.
Footnotes
↵* Dr. Jin has disclosed that he is on the speaker’s bureaus of Merck and Qiagen.
- Copyright © 2013 The Cleveland Clinic Foundation. All Rights Reserved.
- Department of Internal Medicine, Cleveland Clinic; Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
- Director, Primary Care Women’s Health, Medicine Institute, Cleveland Clinic; Assistant Professor of Family Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
- Department of Obstetrics and Gynecology, Cleveland Clinic; Assistant Professor of Surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
- Department of Internal Medicine, Cleveland Clinic; Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
- ADDRESS:
Xian Wen Jin, MD, PhD, Department of Internal Medicine, G10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail jinx{at}ccf.org.
ABSTRACT
In their 2012 guidelines for cervical cancer screening, several organizations call for less-frequent but more-effective screening that incorporates testing for human papillomavirus (HPV). We review these recommendations and the possible future direction of screening.
Footnotes
↵* Dr. Jin has disclosed that he is on the speaker’s bureaus of Merck and Qiagen.
- Copyright © 2013 The Cleveland Clinic Foundation. All Rights Reserved.